Provided by Tiger Trade Technology Pte. Ltd.

Global X Genomics & Biotechnology ETF

66.40
-0.5220-0.78%
Post-market: 66.19-0.2080-0.31%19:30 EDT
Volume:24.85K
Turnover:1.65M
Market Cap:99.91M
PE:- -
High:66.96
Open:66.96
Low:66.07
Close:66.92
52wk High:68.00
52wk Low:37.25
Shares:1.50M
Float Shares:1.50M
Volume Ratio:0.98
T/O Rate:1.65%
Dividend:0.65
Dividend Rate:0.98%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Moderna - FDA Approved Sbla for 2026-2027 Formulas for Spikevax and Mnexspike

THOMSON REUTERS
·
Aug 28

Moderna - Updated Formula for Spikevax is NOW Approved for Individuals 6 Months Through 64 Years of Age with at Least One Underlying Condition

THOMSON REUTERS
·
Aug 28

Moderna: Updated Covid-19 Vaccines Expected Available in Coming Days

THOMSON REUTERS
·
Aug 28

Moderna Inc Stock (MRNA) Moved Down by 5.69% on Aug 27: Key Drivers Unveiled

TradingKey
·
Aug 28

Sector Update: Healthcare

MT Newswires Live
·
Aug 28

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Aug 28

Moderna Shares Down 3.6% After Co Announces $2 Bln Convertible Debt Plans

THOMSON REUTERS
·
Aug 27

Moderna Stock (MRNA) Slides 3% on Plans for a $2B Private Placement

TIPRANKS
·
Aug 27

Moderna Falls After Unveiling $2 Bln Convertible Debt Plans

Reuters
·
Aug 27

Moderna to Sell $2 Billion Convertible Notes in Private Placement

Dow Jones
·
Aug 27

Moderna down 6% to $141.10 after $2B convertible note offering

TIPRANKS
·
Aug 27

Top Premarket Decliners

MT Newswires Live
·
Aug 27

Moderna Plans Private Placement of $2 Billion Convertible Senior Notes Offering

Reuters
·
Aug 27

Moderna to Offer $2 Billion of Convertible Senior Notes Due 2032

MT Newswires Live
·
Aug 27

Moderna Shares Down 5.6% Premarket After Co Announces Proposed Private Placement of $2 Bln of Convertible Senior Notes

THOMSON REUTERS
·
Aug 27

Moderna: Announces Proposed Private Placement of $2.0 Bln of Convertible Senior Notes

THOMSON REUTERS
·
Aug 27

Moderna: to Buy Hedge Overlay Intended to Offset Dilution up to a Cap Initially Equal to at Least a 150% Premium to the Stock Price at Pricing

THOMSON REUTERS
·
Aug 27

Natera and Angiex partner in tumor testing using Signatera

TIPRANKS
·
Aug 27

Natera Partners with Angiex to Use Signatera ctDNA Test in Agx101 Phase I Trial Monitoring

Reuters
·
Aug 27

Natera, - Announces Signatera Collaboration with Angiox to Assess Nd-ADC Therapy Response

THOMSON REUTERS
·
Aug 27